-
IntroducedFeb 26, 2025
-
Passed House
-
Passed Senate
-
Signed into Law
AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name listed with the department of business regulation.)
Last Action See all actions
House • Mar 06, 2025: 03/06/2025 Committee recommended measure be held for further study
Latest Bill Text See all bill texts
Summary/Bill Text
Comments on HB 5632
Tweets
Whip Lists
Sponsors
Votes
Actions
- Mar 06, 2025 | House
- 03/06/2025 Committee recommended measure be held for further study
- Feb 28, 2025 | House
- 02/28/2025 Scheduled for hearing and/or consideration (03/06/2025)
- Feb 26, 2025 | House
- 02/26/2025 Introduced, referred to House Health & Human Services
Bill Texts